{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:32:23Z","timestamp":1790839943518,"version":"4.1.0"},"reference-count":17,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"abstract":"<jats:p>Wernicke's encephalopathy is a triad of ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary vitamin B<jats:sub>1<\/jats:sub>(thiamine) deficiency. A rare genetic defect of thiamine transporter-2 may lead to similar clinical features, biotin-thiamine responsive basal ganglia disease (BTBGD). A 15-year-old girl developed rapid onset ptosis and ophthalmoplegia evolving into a subacute encephalopathy. Neuroimaging demonstrated symmetrical basal ganglia and mid-brain lesions reminiscent of Leigh's subacute necrotising encephalomyelopathy. Oral biotin and thiamine were started, and symptoms improved dramatically the next day. The therapeutic response suggested<jats:italic>SLC19A3<\/jats:italic>, encoding thiamine transporter-2, as a strong candidate gene and Sanger sequencing revealed a novel homozygous c.517A&gt;G;p.Asn173Asp mutation, which segregated with disease within the family. BTBGD is a potentially treatable neurological disorder and should be considered in the differential diagnosis of Leigh syndrome and Wernicke's encephalopathy. Since delayed treatment results in permanent neurological dysfunction or death, prompt diagnosis and early initiation of biotin and thiamine therapy are essential.<\/jats:p>","DOI":"10.1136\/bcr-2013-200838","type":"journal-article","created":{"date-parts":[[2013,10,7]],"date-time":"2013-10-07T23:27:48Z","timestamp":1381188468000},"page":"bcr2013200838","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":39,"title":["Treatable Leigh-like encephalopathy presenting in adolescence"],"prefix":"10.1136","volume":"2013","author":[{"given":"Elisa","family":"Fassone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehani","family":"Wedatilake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J","family":"DeVile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W Kling","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucinda J","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamima","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2013,10,7]]},"reference":[{"issue":"(Pt 7)","key":"2025042709255988000_2013.oct07_2.bcr2013200838.1","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/brain\/121.7.1267","article-title":"Biotin-responsive basal ganglia disease: a novel entity","volume":"2013","author":"Ozand","year":"1998","journal-title":"Brain"},{"key":"2025042709255988000_2013.oct07_2.bcr2013200838.2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/431216","article-title":"Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3","volume":"2013","author":"Zeng","year":"2005","journal-title":"Am J Hum Genet"},{"key":"2025042709255988000_2013.oct07_2.bcr2013200838.3","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJMc0809100","article-title":"Mutations in a thiamine-transporter gene and Wernicke's-like encephalopathy","volume":"2013","author":"Kono","year":"2009","journal-title":"N Engl J Med"},{"key":"2025042709255988000_2013.oct07_2.bcr2013200838.4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1750-1172-8-83","article-title":"Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases","volume":"2013","author":"Alfadhel","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"2025042709255988000_2013.oct07_2.bcr2013200838.5","doi-asserted-by":"crossref","first-page":"e1670","DOI":"10.1542\/peds.2012-2988","article-title":"Reversible lactic acidosis in a newborn with thiamine transporter-2 deficiency","volume":"2013","author":"Perez-Duenas","year":"2013","journal-title":"Pediatrics"},{"issue":"(Pt 3)","key":"2025042709255988000_2013.oct07_2.bcr2013200838.6","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/brain\/awt013","article-title":"Exome sequencing reveals a novel Moroccan founder mutation in SLC19A3 as a new cause of early-childhood fatal Leigh syndrome","volume":"2013","author":"Gerards","year":"2013","journal-title":"Brain"},{"issue":"5","key":"2025042709255988000_2013.oct07_2.bcr2013200838.7","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/brain\/awt054","article-title":"Exome sequencing reveals mutated SLC19A3 in patients with an early-infantile, lethal encephalopathy","volume":"2013","author":"Kevelam","year":"2013","journal-title":"Brain"},{"key":"2025042709255988000_2013.oct07_2.bcr2013200838.8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1471-2350-11-171","article-title":"A wide spectrum of clinical and brain MRI findings in patients with SLC19A3 mutations","volume":"2013","author":"Yamada","year":"2010","journal-title":"BMC Med Genet"},{"key":"2025042709255988000_2013.oct07_2.bcr2013200838.9","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/10372","article-title":"Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness","volume":"2013","author":"Labay","year":"1999","journal-title":"Nat Genet"},{"key":"2025042709255988000_2013.oct07_2.bcr2013200838.10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/10379","article-title":"The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter","volume":"2013","author":"Fleming","year":"1999","journal-title":"Nat Genet"},{"key":"2025042709255988000_2013.oct07_2.bcr2013200838.11","doi-asserted-by":"crossref","first-page":"C851","DOI":"10.1152\/ajpcell.00105.2006","article-title":"Biotin-responsive basal ganglia disease-linked mutations inhibit thiamine transport via hTHTR2: biotin is not a substrate for hTHTR2","volume":"2013","author":"Subramanian","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"2025042709255988000_2013.oct07_2.bcr2013200838.12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.410390311","article-title":"Leigh syndrome: clinical features and biochemical and DNA abnormalities","volume":"2013","author":"Rahman","year":"1996","journal-title":"Ann Neurol"},{"key":"2025042709255988000_2013.oct07_2.bcr2013200838.13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1469-8749.1972.tb02563.x","article-title":"Subacute necrotizing encephalomyelopathy (Leigh's disease): a consideration of clinical features and etiology","volume":"2013","author":"Pincus","year":"1972","journal-title":"Dev Med Child Neurol"},{"key":"2025042709255988000_2013.oct07_2.bcr2013200838.14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/ana.21752","article-title":"SLC25A19 mutation as a cause of neuropathy and bilateral striatal necrosis","volume":"2013","author":"Spiegel","year":"2009","journal-title":"Ann Neurol"},{"key":"2025042709255988000_2013.oct07_2.bcr2013200838.15","doi-asserted-by":"crossref","first-page":"e57195","DOI":"10.1371\/journal.pone.0057195","article-title":"Genome-wide association analysis identifies a mutation in the thiamine transporter 2 (SLC19A3) gene associated with Alaskan Husky encephalopathy","volume":"2013","author":"Vernau","year":"2013","journal-title":"PLoS ONE"},{"key":"2025042709255988000_2013.oct07_2.bcr2013200838.16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nmd.2011.05.001","article-title":"176th ENMC International Workshop: diagnosis and treatment of coenzyme Q(10) deficiency","volume":"2013","author":"Rahman","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"2025042709255988000_2013.oct07_2.bcr2013200838.17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1212\/WNL.0b013e31827deb4c","article-title":"Biotin-responsive basal ganglia disease revisited: clinical, radiologic, and genetic findings","volume":"2013","author":"Tabarki","year":"2013","journal-title":"Neurology"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2013-200838","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T16:26:11Z","timestamp":1745771171000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2013-200838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,7]]},"references-count":17,"alternative-id":["10.1136\/bcr-2013-200838"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2013-200838","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,7]]}}}